These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31508243)

  • 1. Predictive value of genomic screening: cross-sectional study of cystic fibrosis in 50,788 electronic health records.
    Sugunaraj JP; Brosius HM; Murray MF; Manickam K; Stamm JA; Carey DJ; Mirshahi UL
    NPJ Genom Med; 2019; 4():21. PubMed ID: 31508243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Phenotyping on Electronic Health Records Facilitates Genetic Diagnosis by Clinical Exomes.
    Son JH; Xie G; Yuan C; Ena L; Li Z; Goldstein A; Huang L; Wang L; Shen F; Liu H; Mehl K; Groopman EE; Marasa M; Kiryluk K; Gharavi AG; Chung WK; Hripcsak G; Friedman C; Weng C; Wang K
    Am J Hum Genet; 2018 Jul; 103(1):58-73. PubMed ID: 29961570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic health record phenotyping improves detection and screening of type 2 diabetes in the general United States population: A cross-sectional, unselected, retrospective study.
    Anderson AE; Kerr WT; Thames A; Li T; Xiao J; Cohen MS
    J Biomed Inform; 2016 Apr; 60():162-8. PubMed ID: 26707455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
    Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
    Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols.
    Gregg RG; Wilfond BS; Farrell PM; Laxova A; Hassemer D; Mischler EH
    Am J Hum Genet; 1993 Mar; 52(3):616-26. PubMed ID: 7680526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Variants in Individuals Evaluated for Primary Ciliary Dyskinesia.
    Hannah WB; Truty R; Gonzales V; Kithcart GP; Ouyang K; Zeman MK; Li C; Drumm M; Nykamp K; Gaston BM
    J Pediatr; 2019 Dec; 215():172-177.e2. PubMed ID: 31610925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn Screening for Cystic Fibrosis in California.
    Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L;
    Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.
    Gregg RG; Simantel A; Farrell PM; Koscik R; Kosorok MR; Laxova A; Laessig R; Hoffman G; Hassemer D; Mischler EH; Splaingard M
    Pediatrics; 1997 Jun; 99(6):819-24. PubMed ID: 9164776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A maximum likelihood approach to electronic health record phenotyping using positive and unlabeled patients.
    Zhang L; Ding X; Ma Y; Muthu N; Ajmal I; Moore JH; Herman DS; Chen J
    J Am Med Inform Assoc; 2020 Jan; 27(1):119-126. PubMed ID: 31722396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands.
    Dankert-Roelse JE; Bouva MJ; Jakobs BS; Janssens HM; de Winter-de Groot KM; Schönbeck Y; Gille JJP; Gulmans VAM; Verschoof-Puite RK; Schielen PCJI; Verkerk PH
    J Cyst Fibros; 2019 Jan; 18(1):54-63. PubMed ID: 30146269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Genotypical Features of False-Negative Patients in 26 Years of Cystic Fibrosis Neonatal Screening in Tuscany, Italy.
    Taccetti G; Botti M; Terlizzi V; Cavicchi MC; Neri AS; Galici V; Mergni G; Centrone C; Peroni DG; Festini F
    Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32630227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots For Newborn Screening Without Carrier Identification.
    DiBattista A; McIntosh N; Lamoureux M; Al-Dirbashi OY; Chakraborty P; Britz-McKibbin P
    J Proteome Res; 2019 Mar; 18(3):841-854. PubMed ID: 30507207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of cluster headache diagnoses in an electronic health record data repository.
    Rizzoli P; Loder E; Joshi S
    Headache; 2016 Jul; 56(7):1132-6. PubMed ID: 27273524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a semiconductor next-generation sequencing assay for the clinical genetic screening of CFTR.
    Trujillano D; Weiss ME; Köster J; Papachristos EB; Werber M; Kandaswamy KK; Marais A; Eichler S; Creed J; Baysal E; Jaber IY; Mehaney DA; Farra C; Rolfs A
    Mol Genet Genomic Med; 2015 Sep; 3(5):396-403. PubMed ID: 26436105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
    Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Cystic Fibrosis in Nonscreened Populations.
    Sosnay PR; White TB; Farrell PM; Ren CL; Derichs N; Howenstine MS; Nick JA; De Boeck K
    J Pediatr; 2017 Feb; 181S():S52-S57.e2. PubMed ID: 28129813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis.
    Sontag MK; Lee R; Wright D; Freedenberg D; Sagel SD
    J Pediatr; 2016 Aug; 175():150-158.e1. PubMed ID: 27131402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of CFTR gene sequence variants in a northern Portugal population.
    Grangeia A; Alves S; Gonçalves L; Gregório I; Santos AC; Barros H; Barros A; Carvalho F; Moura C
    Pulmonology; 2018; 24(1):3-9. PubMed ID: 29589582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.